Literature DB >> 35320748

Uterine HOXA11 antisense long non-coding RNA prevents decidualization: A new pathway-regulating pregnancy.

Hugh S Taylor1.   

Abstract

Entities:  

Keywords:  HOXA11; HOXA11-AS; antisense RNA; decidualization; endometrium; infertility; lncRNA; long non-coding RNA; pregnancy; recurrent implantation failure

Mesh：

Substances：

Year:  2022        PMID： 35320748      PMCID： PMC9077366          DOI： 10.1016/j.ymthe.2022.03.007

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   12.910


× No keyword cloud information.
  6 in total

1.  HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium.

Authors:  H S Taylor; A Arici; D Olive; P Igarashi
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

2.  Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium.

Authors:  H S Taylor; P Igarashi; D L Olive; A Arici
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

3.  A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes.

Authors:  H S Taylor; G B Vanden Heuvel; P Igarashi
Journal:  Biol Reprod       Date:  1997-12       Impact factor: 4.285

4.  HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse.

Authors:  Kathleen A Connell; Marsha K Guess; Heidi Chen; Vaagn Andikyan; Richard Bercik; Hugh S Taylor
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

5.  HOXA11 silencing and endogenous HOXA11 antisense ribonucleic acid in the uterine endometrium.

Authors:  Y Michael Chau; Susan Pando; Hugh S Taylor
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

6.  Increased expression of HOXA11-AS attenuates endometrial decidualization in recurrent implantation failure patients.

Authors:  Hanting Zhao; Shuanggang Hu; Jia Qi; Yuan Wang; Ying Ding; Qinling Zhu; Yaqiong He; Yao Lu; Yue Yao; Shiyao Wang; Yanzhi Du; Yun Sun
Journal:  Mol Ther       Date:  2022-01-31       Impact factor: 12.910
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.